Cramer: These 'anointed' stocks likely higher by year-end
There are a handful of stocks out there that the market loves and that should move even higher by the end of the year, CNBC's Jim Cramer said Thursday.
"These guys, they are just so loved it's almost like they're going to be marked up between now and year end," he said on "Squawk on the Street".
He also listed Regeneron, Celgene and Seattle Genetics among the "anointed" stocks. Cramer joked that that these companies would have to seriously alienate its users in order to see a significant pullback.
"Where are the big sellers?" Cramer asked, listing several macroeconomic concerns that could give investors pause, but have yet to noticeably slow the rally.
(Related: Why everyone was wrong about Apple)
He later explained that the market is taking negative news and interpreting it as positive, or translating low numbers, like those in housing, as a trough.
"This has been the most contrary year… the optimism is extraordinary," he said.
In addition, this week's record-breaking and oversubscribed debt offering by Verizon is a sign that huge amounts of investor capital is available in the market, Cramer said. "These are extraordinary times."
(Read more: Verizon prices record-breaking $49 billion bond deal)
However, for one much-loved stock, Netflix, the outlook may not be so rosy into year-end.
Cramer pointed to a Morgan Stanley research note released Thursday that downgraded the stock to equal weight.
The analysts captured "the karma of the market," Cramer said, with the idea that Netflix is currently priced for success.